Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
Biotech Stock Roundup: BIIB's Q4 Results, EBS and BPMC Offer Updates
04:48pm, Thursday, 16'th Feb 2023 Zacks Investment Research
Earnings results from Biogen (BIIB) and updates from EBS are the key highlights from the biotech sector during the past week.
Why Axcella Health Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket
12:54pm, Thursday, 16'th Feb 2023 Benzinga
Gainers
Axcella Health Inc. (NASDAQ: AXLA) shares rose 54.1% to $0.9290 in pre-market trading after the company announced FDA clearance of its IND application to initiate a phase 2b/3 trial in the U.
Emergent Biosolutions (EBS) Moves 12.5% Higher: Will This Strength Last?
09:02am, Thursday, 16'th Feb 2023 Zacks Investment Research
Emergent Biosolutions (EBS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength
Emergent's stock jumps after FDA panel favors over-the-counter sales of Narcan
08:23am, Thursday, 16'th Feb 2023
Shares of Emergent BioSolutions Inc. EBS, +12.52% rallied about 19% in premarket trading on Thursday, the day after a Food and Drug Administration advisory committee voted in favor of allowing over-th
Emergent Biosolutions (EBS) Moves 12.5% Higher: Will This Strength Last?
05:16am, Thursday, 16'th Feb 2023
Emergent Biosolutions (EBS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength
Emergent BioSolutions Reports FDA Advisory Committees’ Unanimous Vote in Favor of NARCAN® (naloxone HCI) Nasal Spray for Over-the-Counter Use
10:19pm, Wednesday, 15'th Feb 2023 GlobeNewswire Inc.
GAITHERSBURG, Md., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE:EBS) announced the U.S. Food and Drug Administration (FDA) Nonprescription Drugs Advisory Committee and
Emergent BioSolutions Announces Sale of Travel Health Business to Bavarian Nordic for Up To $380 Million
07:00am, Wednesday, 15'th Feb 2023 GlobeNewswire Inc.
GAITHERSBURG, Md., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced that it has entered into an agreement to sell its travel health business to Bavarian Nordic (BV
Nurix Therapeutics, Inc. (NRIX) Reports Q4 Loss, Lags Revenue Estimates
10:35pm, Thursday, 09'th Feb 2023 Zacks Investment Research
Nurix Therapeutics, Inc. (NRIX) delivered earnings and revenue surprises of -27.94% and 65.46%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the
Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023
09:05pm, Monday, 06'th Feb 2023 GlobeNewswire Inc.
GAITHERSBURG, Md., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Monday, February 27, 2023, at 5:00 pm eastern time to discuss the financial
Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023
04:05pm, Monday, 06'th Feb 2023
GAITHERSBURG, Md., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Monday, February 27, 2023, at 5:00 pm eastern time to discuss the financial r
Is ALPS International Sector Dividend Dogs ETF (IDOG) a Strong ETF Right Now?
11:20am, Thursday, 02'nd Feb 2023 Zacks Investment Research
Smart Beta ETF report for IDOG
Emergent (EBS) to Start Restructuring Plan, Lays Off 5% Workforce
05:06pm, Tuesday, 10'th Jan 2023 Zacks Investment Research
Once this restructuring activity is completed, Emergent BioSolutions (EBS) expects to result in annualized savings of over $60 million. It also slightly raised its total revenue guidance for 2022.
Emergent (EBS) to Start Restructuring Plan, Lays Off 5% Workforce
01:32pm, Tuesday, 10'th Jan 2023
Once this restructuring activity is completed, Emergent BioSolutions (EBS) expects to result in annualized savings of over $60 million. It also slightly raised its total revenue guidance for 2022.
Pharma Stock Falls Amid Workforce Reduction Plans
10:30am, Monday, 09'th Jan 2023
Emergent BioSolutions Inc (NYSE:EBS) is in the news today, after the pharmaceutical company announced it was cutting its workforce by roughly 5%.
Emergent BioSolutions to cut 5% of its workforce in reorganization effort
08:17am, Monday, 09'th Jan 2023
Emergent BioSolutions Inc. EBS, +9.80% is cutting 132 jobs, or approximately 5% of its workforce in a reorganization that the company says will sharpen its strategic focus on core businesses. The biot
